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Abstract: Bcl-X proteins are the one of the best categorized member of the Bcl-2 protein 
families which acts as primary regulators of apoptosis in mammalian cells. The Bcl-X 
proteins are potential anti-cancer drug targets. In this study, the tertiary structure of the beta 
isoform of the apoptosis regulator Bcl-X in humans (h-Bcl-Xβ) has been predicted by   
fold-recognition (threading) approach. In silico assessment of the h-Bcl-Xβ protein revealed 
the characteristic structural features of anti-apoptotic Bcl-2 protein family in h-Bcl-Xβ 
protein. The predicted model was comprised of BH1-BH4 domains, seven alpha-helices and 
a C-terminal transmembrane domain for membrane localization and sub-cellular targeting. 
Quality assessment of the predict model confirmed its reliability as fairly good model.   
Active sites of h-Bcl-Xβ protein were identified using CASTp server. The future work can be 
directed towards drug designing for cancer treatment by regulating the activity of h-Bcl-Xβ 
proteins. 
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Introduction 
The living cells divide in repeated fashion for growth, reproduction, regeneration and 
replacement of damaged cells. The removal of damaged cells comprises of controlled 
sequence of events in which cells undergoes self-termination by apoptosis [5]. An inhibition 
in apoptosis might result in unrestrained tumor growth, which can be cancerous [14, 18] 
whereas enhanced apoptosis may lead to unwanted depletion in cell population as reported in 
neurodegenerative disorders like Alzheimer's and Parkinson's diseases [2, 12]. The members 
of the Bcl-2 (B-cell lymphoma 2) family proteins play a very substantial role in promotion or 
inhibition of apoptotic processes [11, 23]. Bcl-2 proteins play a shielding role in cell survival 
by blocking apoptosis [16, 19]. All the members contain conserved Bcl-2 Homology (BH) 
domains. The Bcl-2 subfamily proteins contain at least BH1 and BH2 which promote cell 
survival by inhibiting caspases activation [22]. Bcl-X proteins are the one of the best 
categorized member of these Bcl-2 protein families. They are leading regulator of apoptosis in 
mammalian cells [3]. Alternative RNA splicing generates three isoforms of the apoptosis 
regulator Bcl-X. The long isoform Bcl-XL has apoptosis repressor activity [10], whereas the 
short isoform Bcl-XS promotes apoptosis [13] but the role of beta-isoform Bcl-Xβ in humans 
is still not clear [1].  
 
In order to gain further understanding of the physiological nature of the Bcl-Xβ proteins, the 
current study aims at in silico sequence analysis, structure modeling and function annotation 
of human Bcl-Xβ (h-Bcl-Xβ) proteins.  
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Methodology 
Sequence retrieval 
The complete primary sequence of h-Bcl-Xβ protein (accession No: AAB17354) was 
retrieved from Genbank database at NCBI. The length of the h-Bcl-Xβ protein was 227 amino 
acids. 
 
Sequence analysis 
Physical and chemical parameters of the protein was computed by ProtParam tool 
(http://web.expasy.org/protparam/) which analyzed for molecular weight, theoretical pI, 
amino acid composition, and grand average of hydropathicity (GRAVY). HSLPred [6] and 
Hum-mPLoc v2.0 [17] servers were used to predict the subcellular localization of h-Bcl-Xβ 
protein. TMPred server [8] was used to check the presence of the transmembrane domains 
within the protein. 
  
Secondary structure prediction 
SOPMA server [7] was used for the secondary structure prediction of the h-Bcl-Xβ protein.  
It assessed the conformational information about positional possibility of the β-strands and 
turns, random coils and α-helices within the protein structure.  
 
Tertiary structure prediction 
The protein sequence of h-Bcl-Xβ protein was submitted to the automated modeling server,  
I-TASSER [24] (http://zhanglab.ccmb.med.umich.edu/I-TASSER) for tertiary structure 
modeling. I-TASSER server predicts the protein structure by threading (fold recognition) 
approach by choosing the templates from proteins of known structures in PDB databank 
having same fold as target protein. The HEX [15] interface and RASMOL were used for 
visualization of the generated model. The model with highest C-score value was selected for 
model refinement and validation. A higher C-score of value signifies a model with a high 
confidence.  
 
Model refinement and validation 
The predicted model was submitted to automated protein structure refinement server  3D
refine 
(http://sysbio.rnet.missouri.edu/3Drefine) for optimization of hydrogen bonding network and 
energy minimization. After refinement, the structural evaluation and stereo-chemical 
assessment of the model were performed using ProSA-web [21] and VERIFY3D. The Psi/Phi 
Ramachandran plot was generated by RAMPAGE sever. 
 
Functional characterization of the predicted structure 
The functional assessment of the predicted model was done by searching against Pfam 
database. The ligand binding site and active site residues of the modeled h-Bcl-Xβ protein was 
assessed by CASTp [4] and 3DLigandSite [20] servers respectively.  
 
Model Submission  
The predicted model of h-Bcl-Xβ protein was successfully submitted in Protein Model Data 
Base (http://mi.caspur.it/PMDB) having PMID PM0079226. 
 
Results and discussion 
Primary sequence analysis 
The physiochemical properties of h-Bcl-Xβ protein were assessed by ProtParam tool.   
The h-Bcl-Xβ protein was predicted to have molecular weight of 25290.3 Daltons and the   INT. J. BIOAUTOMATION, 2014, 18(1), 23-30 
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theoretical isoelectric point (pI) of 4.73, indicating that the protein is negatively charged. The 
negative Grand average of hydropathicity (GRAVY) value of -0.175 for protein indicates that 
it is hydrophilic and soluble in nature. The subcellular localization prediction using HSLPred 
and Hum-mPLoc v2.0 servers predicted that the query protein is cytoplasmic and localized in 
mitochondria. Furthermore, TMPred server predicted that the sequence positions 137-155 and 
207-225 are probable transmembrane helix regions of the protein. 
 
Secondary structure prediction 
The secondary structure prediction of h-Bcl-Xβ protein using SOPMA (with default 
parameters) showed that the protein having the composition of Helix = 48.46%,   
Strand = 6.61%, and Coil = 44.93% (Fig. 1). As evident from this secondary structure 
prediction, h-Bcl-Xβ protein is mostly comprised of alpha helix and loops with traces of beta 
turns and strands. 
 
Tertiary structure prediction by threading approach 
The 3D structure of the h-Bcl-Xβ protein was generated using I-TASSER protein prediction 
server. In accordance with the secondary structure prediction, the predicted 3D structure of 
the h-Bcl-Xβ protein (Fig. 2) mainly comprised of alpha helices and beta turns/coils.  
 
Interestingly, the predicted 3D model of h-Bcl-Xβ protein has the characteristic features of 
anti-apoptotic members, namely BH1-BH4 domains, seven alpha-helices and a C-terminal 
transmembrane (TM) domain for membrane localization and sub-cellular targeting. The 
presence of these features suggests that h-Bcl-Xβ protein is anti-apoptotic in nature.  
 
 
Fig. 1 Secondary structure prediction of h-Bcl-Xβ protein using 
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Fig. 2 Predicted tertiary structure of h-Bcl-Xβ protein, viewed in  
(A) RasMol and (B) HEX interface 
 
Model refinement and quality assessment 
The predicted 3D model was submitted 3D
refine server for refinement and the refined structure 
was validated by VERIFY3D, ProSA-web and Ramachandran Plot assessments.   
The predicted structure passed the VERIFY3D evaluation with 80.26% of the residues having 
an averaged 3D-1D score > 0.2. The residues with score over 0.2 suggest that the predicted 
tertiary structure is of good quality. The calculated Z-score of -6.06 (Fig. 3A) by ProSA-web 
indicated that the overall quality of the predicted tertiary structure lies within the score range 
of experimentally determined protein tertiary structures by NMR and X-ray crystallography. 
RAMPAGE server was used to determine the Ramachandran Plot to assure the model quality. 
The Ramachandran Plot revealed that 91.6% (> 90% for a good model) of the overall residues 
are in the most favored region (Fig. 3B). 
 
Functional annotation of the predicted structure 
The predicted model was searched against the Pfam database for conserved domains using 
BLAST by POLYVIEW-3D. The results showed that the modeled h-Bcl-Xβ protein structure 
belongs to the family of Bcl-2 apoptosis regulator proteins with homologous BH4 domains 
(Fig. 4). The ligand binding sites (pockets) of the predicted model was assessed by CASTp 
server. Out of 35 predicted structural pockets, the pockets with volume > 500 Å
3 were 
reported (Fig. 5). Pocket 1 (green) is located in cavity between α1, α5 and α6 helices and 
Pocket 2 (blue) is located in cavity between α7 helix and BH2 domain of α6 helix. 
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Fig. 3 (A) Z-score plot and (B) Ramachandran plot  
for predicted tertiary structure of h-Bcl-Xβ protein 
 
 
 
Fig. 4 Identification of superfamily for predicted model by protein annotation  
(as viewed in POLYVIEW-3D) 
 
 
 
 
Fig. 5 Predicted ligand binding sites of the tertiary structure of h-Bcl-Xβ protein  
(as viewed in POLYVIEW-3D). 
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Conclusion 
The main objective of the study was to perform sequence analysis and predict the tertiary 
structure and function of h-Bcl-Xβ protein. The 3D structure modeling resulted in high quality 
structure of h-Bcl-Xβ protein [1] with all the unique characteristic features of Bcl-2   
anti-apoptotic protein family. This suggested that h-Bcl-Xβ protein is an anti-apoptotic 
protein. The predicted ligand binding sites can be used for designing anti-cancer drugs 
targeting h-Bcl-Xβ proteins [9] and to understand the protein-protein interaction between the 
anti-apoptotic and pro-apoptotic proteins.  
 
Acknowledgements 
The authors thank the Head, Department of Biotechnology, Bengal Institute of Technology for 
providing facilities required successful completion of the project.  
 
References 
1.  Ban J., L. Eckhart, W. Weninger, M. Mildner, E. Tschachler (1998). Identification of a 
Human cDNA Encoding a Novel Bcl-x Isoform, Biochemical and Biophysical Research 
Communications, 248, 147–152. 
2.  Behl C. (2007). Apoptosis and Alzheimer's Disease, Journal of Neural Transmission, 107, 
1325-1344. 
3.  Boise L. H., M. González-Garcia, C. E. Postema, L. Ding, T. Lindsten, L. A. Turka,  
X. Mao, G. Nunez, C. B. Thompson (1993). Bcl-x, a Bcl-2-related Gene that Functions as 
a Dominant Regulator of Apoptotic Cell Death, Cell, 74, 597-608. 
4.  Dundas J., Z. Ouyang, J. Tseng, A. Binkowski, Y. Turpaz, J. Liang (2006). CASTp: 
Computed Datas of Surface Topography of Proteins with Structural and Topographical 
Mapping of Functionally Annotated Residues, Nucleic Acids Research, 34, W116-W118. 
5.  Elmore S. (2007). Apoptosis: A Review of Programmed Cell Death, Toxicologic 
Pathology, 35, 495-516. 
6.  Garg A., M. Bhasin, G. Raghava (2005). SVM-based Method for Subcellular Localization 
of Human Proteins using Amino Acid Compositions, their Order and Similarity Search, 
The Journal of Biological Chemistry, 280, 14427-14432. 
7.  Geourjon C., G. Deleage (1995). SOPMA: Significant Improvements in Protein 
Secondary Structure Prediction by Consensus Prediction from Multiple Alignments, 
Computer Applications in the Biosciences, 11, 681-684. 
8.  Hofmann K., W. Stoffel (1993). TMbase – A Database of Membrane Spanning Proteins 
Segments, Biological Chemistry Hoppe-Seyler, 374, 166. 
9.  Huang Z. (2000). Bcl-2 Family Proteins as Targets for Anticancer Drug Design, 
Oncogene, 19, 6627-6631. 
10. Jeong H. S., H. Y. Choi, T. W. Choi, B. W. Kim, J. H. Kim, E. R. Lee, S. G. Cho (2008). 
Differential Regulation of the Anti-apoptotic Action of B-cell Lymphoma 2 (Bcl-2) and 
B-cell Lymphoma Extra-long (Bcl-xL) by c-Jun N-terminal Protein Kinase (JNK)   
1-Involved Pathway in Neuroglioma Cells, Biological & Pharmaceutical Bulletin, 31, 
1686-1690. 
11. Korsmeyer S. J. (1992). Bcl-2: An Antidote to Programmed Cell Death, Cancer Surveys, 
15, 105-118. 
12. Lev N., E. Melamed, D. Offen (2003). Apoptosis and Parkinson's Disease, Progress in 
Neuro-Psychopharmacology and Biological Psychiatry, 27, 245-250. 
13. Lindenboim L., J. Yuan, R. Stein (2000). Bcl-xS and Bax Induce Different Apoptotic 
Pathways in PC12 cells, Oncogene, 19, 1783-1793. 
14. Lowe S. W., A. W. Lin (2000). Apoptosis in Cancer, Carcinogenesis, 21, 485-495.   INT. J. BIOAUTOMATION, 2014, 18(1), 23-30 
 
 29
15.  Macindoe G., L. Mavridis, V. Venkatraman, M. D. Devignes, D. W. Ritchie (2010).  
Hex Server: an FFT-based Protein Docking Server Powered by Graphics Processors, 
Nucleic Acids Research, 38, W445-W449. 
16. Reed J. C. (2008). Bcl-2-family Proteins and Hematologic Malignancies: History and 
Future Prospects, Blood, 111, 3322-3330. 
17. Shen H., K. Chou (2009). A Top-down Approach to Enhance the Power of Predicting 
Human Protein Subcellular Localization: Hum-mPLoc 2.0, Analytical Biochemistry, 394, 
269-274. 
18. Taylor R. C., S. P. Cullen, S. J. Martin (2008). Apoptosis: Controlled Demolition at the 
Cellular Level, Nature Reviews of Molecular Cell Biology, 9, 231-241. 
19. Van Delft M. F., D. C. Huang (2006). How the Bcl-2 Family of Proteins Interact to 
Regulate Apoptosis, Cell Research, 16, 203-213. 
20. Wass M. N., L. A. Kelley, M. J. Sternberg (2010). 3DLigandSite: Predicting Ligand-
binding Sites using Similar Structures, Nucleic Acids Research, 38, W469-W473. 
21. Wiederstein M., M. J. Sippl (2007). ProSA-web: Interactive Web Service for the 
Recognition of Errors in Three-dimensional Structures of Proteins, Nucleic Acids 
Research, 35, W407-W410.  
22. Willis S., C. L. Day, M. G. Hinds, D. C. S. Huang (2003). The Bcl-2-regulated Apoptotic 
Pathway, Journal of Cell Science, 116, 4053-4056. 
23. Youle R. J., A. Strasser (2008). The BCL-2 Protein Family: Opposing Activities that 
Mediate Cell Death, Nature Reviews Molecular Cell Biology, 9, 47-59. 
24. Zhang Y. (2008). I-TASSER Server for Protein 3D Structure Prediction, BMC 
Bioinformatics, 9, 40, doi:10.1186/1471-2105-9-40. 
 
 
 
Tapan Kumar Pal, Ph.D. 
E-mail: tapankpal@gmail.com  
 
 
 
 
Dr. Tapan Kumar Pal is currently an Assistant Professor, Department 
of Biotechnology, Bengal Institute of Technology, Kolkata. He has 
completed B.Sc. in Chemistry and M.Sc. in Biochemistry from 
University of Calcutta. He has completed his Ph.D. in Biochemistry 
from University of Calcutta. With more than 11 years of teaching and 
research experience, he has contributed more than 10 publications in 
journals in national and international levels. He is also a guest 
faculty, Department of Home Science, University of Calcutta and 
Department of Food and Nutrition, Sarada Ma Girl’s college, 
Barasat. His areas of interests are microbial biotechnology, plant 
protection and bioinformatics. 
 
   INT. J. BIOAUTOMATION, 2014, 18(1), 23-30 
 
 30
 
Anjali Singh 
E-mail: singhanjali123@gmail.com  
 
 
 
 
Anjali Singh is presently in pre-final year of her B.Tech degree in 
Biotechnology from Bengal Institute of Technology, Kolkata, India. 
Her research interests include bioinformatics, molecular biology and 
genetics. 
 
 